Literature DB >> 17120489

Circulation and antigenic drift in human influenza B viruses in SE Asia and Oceania since 2000.

Ian G Barr1, Naomi Komadina, Chris Durrant, Helen Sjogren, Aeron C Hurt, Robert P Shaw.   

Abstract

During annual influenza epidemics, influenza B viruses frequently co-circulate with influenza A viruses and in some years, such as 2005, large outbreaks have occurred while in other years, the virus virtually disappears. Since 1987 there have been two lineages of influenza B viruses co-circulating in various countries and causing disease in humans. The proportions of these two lineages vary from year to year and country to country. For example, in 2005, the B/Victoria/2/87 lineage was predominant in New Zealand while in Australia the B/Yamagata/16/88 lineage was more common. Antigenic and genetic analysis has revealed gradual movement in the both lineages. Careful monitoring of the two virus lineages is important, as they are antigenically distinct. This is an important consideration for influenza vaccine formulation decisions, as only one influenza B component is traditionally included in the annual trivalent influenza vaccine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17120489

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  15 in total

1.  Circulation of influenza B lineages in northern Viet Nam, 2007-2014.

Authors:  Thi Thanh Le; Thu Hang Pham; Thi Hien Pham; Le Khanh Hang Nguyen; Co Thach Nguyen; Vu Mai Phuong Hoang; Thu Huong Tran; Vu Son Nguyen; Huong Giang Ngo; Quynh Mai Le
Journal:  Western Pac Surveill Response J       Date:  2015-11-11

2.  The coming era of quadrivalent human influenza vaccines: who will benefit?

Authors:  Ian G Barr; Lauren L Jelley
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

3.  Genetic characterisation of influenza B viruses detected in Singapore, 2004 to 2009.

Authors:  Muhammad Raihan Jumat; Richard J Sugrue; Boon-Huan Tan
Journal:  BMC Res Notes       Date:  2014-12-01

4.  Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6-35 Months of Age During 2013-2014: Results From A Phase II Randomized Trial.

Authors:  Long Wang; Vijayalakshmi Chandrasekaran; Joseph B Domachowske; Ping Li; Bruce L Innis; Varsha K Jain
Journal:  J Pediatric Infect Dis Soc       Date:  2015-07-16       Impact factor: 3.164

5.  Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014.

Authors:  Mpho Seleka; Florette K Treurnicht; Stefano Tempia; Orienka Hellferscee; Senzo Mtshali; Adam L Cohen; Amelia Buys; Johanna M McAnerney; Terry G Besselaar; Marthi Pretorius; Anne von Gottberg; Sibongile Walaza; Cheryl Cohen; Shabir A Madhi; Marietjie Venter
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

6.  Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults.

Authors:  Jiří Beran; Mathieu Peeters; Walthère Dewé; Jolana Raupachová; Lenka Hobzová; Jeanne-Marie Devaster
Journal:  BMC Infect Dis       Date:  2013-05-20       Impact factor: 3.090

7.  Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example.

Authors:  Jirí Beran; Veronika Wertzova; Karel Honegr; Eva Kaliskova; Martina Havlickova; Jirí Havlik; Helena Jirincova; Pascale Van Belle; Varsha Jain; Bruce Innis; Jeanne-Marie Devaster
Journal:  BMC Infect Dis       Date:  2009-01-17       Impact factor: 3.090

8.  Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers.

Authors:  Josefina García; Merly Sovero; Alberto L Torres; Jorge Gomez; Richard Douce; Melvin Barrantes; Felix Sanchez; Mirna Jimenez; Guillermo Comach; Ivette de Rivera; Roberto Agudo; Tadeusz Kochel
Journal:  Influenza Other Respir Viruses       Date:  2009-03       Impact factor: 4.380

9.  Integrating influenza antigenic dynamics with molecular evolution.

Authors:  Trevor Bedford; Marc A Suchard; Philippe Lemey; Gytis Dudas; Victoria Gregory; Alan J Hay; John W McCauley; Colin A Russell; Derek J Smith; Andrew Rambaut
Journal:  Elife       Date:  2014-02-04       Impact factor: 8.140

10.  Retrospective review of factors associated with severe hospitalised community-acquired influenza in a tertiary paediatric hospital in South Australia.

Authors:  Nerissa Lakhan; Michelle Clarke; Suja M Mathew; Helen Marshall
Journal:  Influenza Other Respir Viruses       Date:  2016-08-08       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.